An allergen extract of five grass pollens is indicated for the management of allergic rhinitis caused by grass pollen with clinically relevant symptoms and diagnosed with specific tests.
The allergenic extract has shown modest efficacy in trials compared to placebo.
There are no comparative trials with other immunotherapies.
A high percentage of patients included in the trials suffered local adverse reactions, especially children, of which the most frequent was oral pruritus (32%). Although rare, there is a risk of severe adverse reactions (angioedema, dysphagia, and respiratory problems).